679. In vitro Activity of Cefiderocol (CFDC), a Novel Siderophore Cephalosporin, Against Difficult-to-Treat-Resistant (DTR) Gram-Negative Bacterial Pathogens From the Multi-National Sentinel Surveillance Study, SIDERO-WT (2014â2017)
Longshaw, Christopher, Tsuji, Masakatsu, Hackel, Meredith M, Sahm, Daniel F, Yamano, YoshinoriVolume:
6
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofz360.747
Date:
October, 2019
File:
PDF, 758 KB
2019